ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $14,546 | -84.9% | 13,853 | -1.7% | 0.00% | -100.0% |
| Q3 2023 | $96,496 | -33.8% | 14,087 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $145,699 | +33.2% | 14,050 | +3.9% | 0.00% | 0.0% |
| Q1 2023 | $109,417 | -47.2% | 13,525 | +2.7% | 0.00% | -50.0% |
| Q4 2022 | $207,412 | +4.2% | 13,169 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $199,000 | +22.8% | 12,665 | +9.0% | 0.00% | 0.0% |
| Q2 2022 | $162,000 | -24.3% | 11,615 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $214,000 | +18.9% | 12,413 | +0.5% | 0.00% | +100.0% |
| Q4 2021 | $180,000 | -17.4% | 12,357 | +2.3% | 0.00% | -50.0% |
| Q3 2021 | $218,000 | – | 12,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,808,034 | $29,119,313 | 14.32% |
| Foresite Capital Management V, LLC | 1,258,243 | $13,047,980 | 9.53% |
| GREAT POINT PARTNERS LLC | 1,941,581 | $20,134,195 | 3.94% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $35,258,000 | 3.63% |
| Aisling Capital Management LP | 434,455 | $4,505,298 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 651,400 | $6,755,018 | 2.09% |
| VR Adviser, LLC | 1,040,754 | $10,792,619 | 1.73% |
| Ikarian Capital, LLC | 796,300 | $8,257,631 | 1.32% |
| Samsara BioCapital, LLC | 696,171 | $7,219,293 | 1.27% |
| BRAIDWELL LP | 2,901,194 | $30,085,382 | 0.98% |